Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$474.45
+2.08%
Alpha Vantage · 11/6/2026
Adjusted daily closes · 252 observations · as of Nov 6, 2026
1 month
-3.4%
3 months
-14.7%
6 months
-21.7%
1 year
+9.8%
Year to date
+5.8%
52-week range
$423.39 – $648.89
Latest reported period: Sep 26, 2026
Market cap
$15.02B
P/E
42.4
P/B
4.2
P/S
7.4
Revenue
$2.02B
Net income
$354.4M
Diluted EPS
11.18
Gross margin
45.50%
Net margin
17.50%
Return on equity
10.40%
Total debt
$775.9M
Cash
$89.3M
Free cash flow
$399.5M
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Sep 26, 2026 | $524.6M | $93.8M | 45.60% | 17.90% | $85.9M |
| Jun 27, 2026 | $519.5M | $101.5M | 47.70% | 19.50% | $146.9M |
| Mar 28, 2026 | $518M | $91.7M | 44.40% | 17.70% | $67.6M |
| Dec 27, 2025 | $461.6M | $67.4M | 44.30% | 14.60% | $99.1M |
| Sep 27, 2025 | $455.3M | $60M | 44.10% | 13.20% | $71.7M |
| Jun 28, 2025 | $436M | $68.5M | 44.80% | 15.70% | $104.3M |
| Mar 29, 2025 | $437.7M | $72.7M | 44.20% | 16.60% | $55M |
| Dec 28, 2024 | $394.4M | $57.9M | 44.30% | 14.40% | $73.6M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
RBC Capital downgraded Medical Properties Trust to Underperform from Sector Perform and lowered its price target to $2 from $4.50, a 55.6% decrease.The price target implies a downside of 18.0% from the Oct 29 close of $2.44.Explore more price target data and ratings for Medical Properties Trust on...
Original sourceMedical Properties Trust NYSE:MPT was trading lower as RBC Capital Markets cut its recommendation on the stock after the third-quarter results announcement.Shares were 1.23% lower at $2.41 during pre-market trading on Friday.MPT was trading higher despite third-quarter earnings missing analyst expe...
Original source